FDA Adverse Event Malfunction Summary report: N

ARCHITECT TOTAL T3

MDR report key: 4172410 · Received October 15, 2014

Report

Report Number
3005094123-2014-00103
Event Type
Malfunction
Date Received
October 15, 2014
Date of Event
August 7, 2014
Report Date
August 7, 2014
Manufacturer
A.I.D.D LONGFORD
Product Code
CDP
PMA / PMN Number
K983439
Removal / Correction Number
3005094123-09/16/14-001-
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

COMPLETE CORRECTION AND OR REMOVAL REPORTING NUMBER IS 3005094123-09/16/14-001-R. (B)(4). FURTHER ANALYSIS OF THE DATA INDICATES THE REDUCED RLU VALUES ARE EVIDENT FOR MICROPARTICLE BOTTLES SEQUENTIALLY NUMBERED FROM 13835 ONWARDS. (B)(4). THE INVESTIGATION HAS DETERMINED THAT (B)(4) OF THE TWO IMPACTED REAGENT LOTS (38901UI00 AND 38901UI01) MAY EXHIBIT LOWER RELATIVE LIGHT UNITS (RLUS) THAN EXPECTED, WHICH IN TURN MAY RESULT IN CONTROLS OUT OF RANGE OR PATIENT RESULTS HIGHER THAN EXPECTED. INTERNAL TESTING OF FILE SAMPLES CONFIRMED THE CUSTOMERS OBSERVATION AND IT WAS DETERMINED THAT THE REDUCTION IN RLUS WAS RELATED TO THE EXISTENCE OF REDUCED PERCENT SOLIDS FROM THIS PORTION OF THE FILL. FOUR POSSIBLE UTILISATION SCENARIOS WITH THE IMPACTED REAGENT MAY BE OBSERVED: 1-THE CUSTOMER CALIBRATES WITH A NOMINAL SOLIDS BOTTLE AND GENERATES RESULTS FROM THE CURVE USING A NOMINAL SOLIDS BOTTLE. NO IMPACT WILL OCCUR. 2-THE CUSTOMER CALIBRATES WITH A NOMINAL SOLIDS BOTTLE AND LATER GENERATES RESULTS FROM THAT CURVE USING A LOW SOLIDS BOTTLE. THIS WILL RESULT IN A POSITIVE BIAS WHEN COMPARED TO SCENARIO 1. 3-THE CUSTOMER CALIBRATES WITH A LOW SOLIDS BOTTLE AND LATER GENERATES RESULTS FROM THAT CURVE USING A NOMINAL SOLIDS BOTTLE. THIS WILL RESULT IN A NEGATIVE BIAS WHEN COMPARED TO SCENARIO 1. 4-THE CUSTOMER CALIBRATES WITH A LOW SOLIDS BOTTLE AND GENERATES RESULTS FROM THAT CURVE USING A LOW SOLIDS BOTTLE. THIS WILL RESULT IN A POSITIVE BIAS WHEN COMPARED TO SCENARIO1. THE CORRECTION ACTIONS INCLUDED: 1-INTERNAL INTERIM ACTION: ADDITIONAL VERIFICATIONS HAVE BEEN INTRODUCED DURING FILLING PROCESS TO RECORD INFORMATION SUCH AS ACTUAL BOTTLE NUMBERS TESTED AND MIX SPEEDS PRIOR TO TRANSFER. 2-QUALITY HOLD FOR THE AFFECTED REAGENT LOTS WAS ISSUED. 3-A FIELD SAFETY CORRECTIVE ACTION (FSCA) IS PROPOSED FOR ISSUE TO ALL CUSTOMERS TO INFORM THEM OF THE EVENT AND INSTRUCT THEM TO: DISCONTINUE USAGE OF ARCHITECT TT3 REAGENT, LN 7K64-20, LOT 38901UI00 AND LN 7K64-25, LOT 38901UI01. (ALTERNATE IS TO ONLY DESTROY IMPACTED BOTTLES BASED ON SERIAL NUMBERS). REVIEW PATIENT RESULTS GENERATED USING THE LOTS ABOVE TO ENSURE ALIGNMENT TO OVERALL CLINICAL STATUS. 4-A QUALITY DIRECTIVE (QD) WITH Q&A WILL BE PROVIDED TO CALL REGISTRATION TO SUPPORT THEM WITH ANY QUERIES IMPACTED CUSTOMERS MAY HAVE. REPLACEMENT INVENTORY ARE AVAILABLE (7K64-20 AND 7K64-25; LOT 41919UI00; EXP: 20-MAY-2015, 7K64-30; LOT 41918UI01; EXP: 20-MAY-2015).

Description of Event or Problem · 1

THE CUSTOMER STATED THAT WHEN THEY STARTED USING A NEW LOT OF ARCHITECT TOTAL T3 REAGENT (38901UI00) THE QC AND PATIENT RESULTS SHIFTED UP BY 25-30%. THE CUSTOMER TRIED TO CALIBRATE BUT THE CONTROLS CONTINUED TO BE OUT OF RANGE. THERE WERE NO PATIENT RESULTS PROVIDED. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
653770 ARCHITECT TOTAL T3 TOTAL T3 CDP A.I.D.D LONGFORD 38901UI00

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT I2000SR ANALYZER, LIST # 03M74-02,| SERIAL # (B)(4)